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ABSTRACT
Objective: To describe the profile of cytopathologic exams collected in a Family Health Strategy (FHS) in the 
metropolitan area of Porto Alegre/RS. Methods:It is a qualitative research with a retrospective descriptive 
transversal approach. Research was conducted in a FHS unit in the metropolitan area of Porto Alegre/RS, 
where 201 reports were used for the study about women who were submitted to Pap test. Inclusion criteria 
were to have done the Pap test in the health unit throughout the studied period no matter age. The studied 
period was from January of 2014 to December of 2015. It was used a form containing study variables for 
data collection. Data analysis was conducted on SPSS program, 21.0 version. Citopathologic exams results 
were classified according 2001 Bethesda system. Study respected ethical aspects of research involving human 
legislation according to resolution n. 466/2012. Results:From the reports total, 3% registered normal results and 
95% of reports described atypical cells of undetermined significance possibly not neoplastic squamous (ASC-
US) and glandular (AGUS). In sample total, 4 women showed neoplasms accounting for 2% in sample total. 
Conclusion:It is suggested to implement strategies for qualification of collection and laboratory analysis of 
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citopathologic material in order to acquire diagnosis safety, 
treatment and progression prevention of citopathologic 
lesions.
Descriptors: Uterine cervical neoplasms, Nursing 
care,Women’s health.
RESUMO
Objetivo:Descrever o perfil dos exames citopatológicos coletados em um 
serviço de Estratégia da Saúde da Família (ESF) na região metropolitana 
de Porto Alegre-RS. Método:Estudo transversal descritivo retrospectivo, 
realizado em um serviço de ESF na região metropolitana de Porto Alegre-
RS. A amostra foi composta de 201 prontuários com laudos de exames de 
mulheres que realizaram o exame de câncer do colo do útero no período 
de janeiro de 2014 a dezembro de 2015. Os dados foram analisados no 
programa SPSS versão 21.0. Os resultados dos exames citopatológicos 
foram classificados de acordo com o sistema de Bethesda, 2001. 
Resultados: 3% tiveram resultados dentro dos limites da normalidade e 
95% dos laudos registraram células atípicas de significado indeterminado, 
possivelmente não neoplásicas escamosas (ASC-US) e glandulares 
(AGUS) e 2% das mulheres apresentaram neoplasia. Conclusão:Sugere-
se implantar estratégias para qualificação do processo de coleta e análise 
laboratorial de material citopatológico, garantindo segurança diagnóstica.
Descritores: Neoplasias do colo do útero, Cuidados de enfermagem,Saúde 
da mulher.
RESUMEN
Objetivo: Describir el perfil de los exámenes citopatológicos recogidos 
en un servicio de Estrategia de Salud de la Familia (ESF) en la región 
metropolitana de Porto Alegre-RS. Métodos: Estudio transversal 
descriptivo retrospectivo, realizado en un servicio de ESF en la región 
metropolitana de Porto Alegre-RS. La muestra fue compuesta de 201 
prontuarios con laudos de exámenes de mujeres que realizaron el examen 
de cáncer del cuello del útero en el período de enero de 2014 a diciembre 
de 2015. Los datos fueron analizados en el programa SPSS versión 
21.0. Los resultados de los exámenes citopatológicos se clasificaron de 
acuerdo con el sistema de Bethesda, 2001. Resultados: Los 3% tuvieron 
resultados dentro de los límites de la normalidad y los 95% de los laudos 
registraron células atípicas de significado indeterminado, posiblemente 
no neoplásicas escamosas (ASC-US) Glandulares (AGUS) y los 2% de 
las mujeres presentaron neoplasia. Conclusión: Se sugiere implantar 
estrategias para calificar el proceso de recolección y análisis de laboratorio 
de material citopatológico, garantizando seguridad diagnóstica.
Descriptores:Neoplasias del cuello del útero,Cuidados de enfermeira, 
Salud de la mujer.
INTRODUCTION
Cervical Cancer (CC) is a public health problem because 
of its high incidence. It is the fourth most common type of 
cancer among women, registering 530 thousand new cases in 
the world, being more frequent in less developed countries.1 
In Brazil, in the year 2014, 15,590 new cases of CC were 
registered, with an estimated risk of 15.33 cases per 100,000 
women, with a higher incidence in the years 2012 to 2013.2 
The Southeast region has a lower incidence in the country, 
with 15.53 cases per 100,000 women and the Central-West 
region has a higher incidence with 27.71 cases.3 Specifically, 
in the Rio Grande do Sul State, an incidence of 15.05 cases per 
100,000 women was registered in the years 2012 to 2013.3 In 
2011, 115 deaths of diagnosed women were confirmed with 
CC in the metropolitan region of Porto Alegre city.4
CC is considered rare in women up to the age of 30, and its 
incidence progressively increases in the age group from 40 to 
50 years old. The first factor for the development of CC is the 
Human Papilloma Virus (HPV) that can be contracted during 
intercourse. More than 90% of spinocellular CCs contain 
deoxyribonucleic acid (DNA) from HPV. The virus represents 
an important causal factor in the development of this type 
of cancer and its precursor, the dysplasia of the cervix.5 The 
early onset of sexual life, the multiplicity of sexual partners, 
smoking, low socioeconomic status, immunosuppression and 
use of oral contraceptives, are factors that can favor infection 
by the virus.6
When diagnosed and treated early, CC has a better 
prognosis. This type of cancer presents a long evolutionary 
period of the precursor lesions and easy detection of the 
alterations in the initial phase, which attributes to it, high 
efficacy with respect to the prevention and the cure.7 
The Papanicolau, or cytopathological examination, is 
internationally recognized as effective screening practice 
for reducing CC mortality. In Brazil, the exam compiles the 
program’s care line for CC control, as well as its diagnosis, 
follow-up, and treatment of precursor or invasive lesions 
found.8
Countries with coverage of more than 50% of the 
cytopathological examination, performed in the period of 
3 to 5 years, have rates lower than three deaths per hundred 
thousand women per year. In countries with coverage greater 
than 70%, this rate is equal to or less than two deaths per 
100,000 women per year.9
Given these findings, the Family Health Strategy (FHS) 
is an appropriate initiative for the production of educational 
and preventive services in relation to the CC, serving as an 
access door. The professionals that make up the FHS team 
have an assigned area, which has the opportunity of knowing 
the community where the users are actively searching for 
the cytology, whose objective is to carry out the previous 
diagnosis and the appropriate treatment of the altered cases.10
The nurse plays a fundamental role in the prevention of this 
type of cancer, which is done through monitoring activities, 
prevention of risk factors, clarification of doubts and the 
execution of preventive tests, seeking to guarantee the quality 
and safety of the care in primary care.10 In this context, the 
Ministry of Health advocates coverage of cytopathological 
examinations of 80% of Brazilians within the age group from 
25 to 64 years old.11
The relevance of this study is due to the potential thematic 
has to contribute to the implementation and strengthening of 
public health policies for women in disease prevention and 
health promotion. The CC has a high incidence, remaining 
one of the most prevalent among the malignant neoplasias 
that occur in Brazilian women. For this reason, it is necessary 
to track cervicovaginal changes in women who are still 
adolescents or young people.12,13 It is hoped that the knowledge 
generated by this study contributes to the qualification of 
women’s care in the primary care setting and with knowledge 
of the nuances of this process.
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Hence, considering that CC is one of the priorities of 
health policies in the context of comprehensive health care 
for women in Brazil, the following question arises: What is 
the profile of cytopathological exams collected in a Family 
Health Strategy service located in the region metropolitan 
of Porto Alegre city?
In order to do so, this study aimed to describe the profile 
of the cytopathological exams collected in a FHS service 
situated in the metropolitan region of Porto Alegre city. 
METHODS
It is a retrospective, descriptive and cross-sectional study 
with a qualitative approach, which was carried out in a FHS 
service that assists a population of 4,000 people, and is situated 
in the metropolitan area of Porto Alegre city, Rio Grande do Sul 
State. It has an estimated population of 138,357 inhabitants.14
The sample calculation was performed through the 
WinPEPI program (Programs for Epidemiologists for 
Windows), version 11.43. For a 95% confidence level, a sample 
of 350 exams for this temporal cut-off, and a 5% margin of 
error, a total of 188 files were obtained with cytopathological 
exams. The time cut analyzed covered the period from January 
2014 to December 2015. The inclusion criteria were records 
of women who underwent CC examinations in the service 
studied in the predicted period, regardless the women’s age.
The medical records of women who did not collect the 
cytopathological examination during the study period and 
the medical records not found during the period of data 
collection were excluded.
Data collection was done using a standardized form, 
extracting the data from the patients’ medical records, and, 
later, the data were inserted into a database in the Excel 
program. Thus, variables were characterized as follows: 
age, color, marital status, schooling, occupation, alcohol 
and drug consumption, smoking, Human Immunodeficiency 
Virus (HIV), Body Mass Index (BMI), age of menarche, 
use of method contraceptive, pregnancy at the time of the 
examination, age of last menstruation, use of hormone/
menopause medication, number of pregnancies, number of 
abortions, vaginal delivery, cesarean birth, first gestation age, 
family history of cancer, chemotherapy and/or radiotherapy, 
the reason for performing the cytopathological examination, 
the examination at some other time, the periodicity of the 
examination, bleeding after sexual intercourse, a history of 
Sexually Transmitted Infections (STIs), inspection of the 
cervix and the epithelium represented in the sample.
The results of the cytopathological examinations were 
classified according to the Bethesda system, 2001.15 This 
nomenclature is grouped as folows: atypicals squamous cells 
(ASC), possibly non-neoplastic (ASC-US), and cannot exclude 
high-grade intraepithelial lesion; atypical glandular cells 
(AGC), non-neoplastic (AGUS), high-grade intraepithelial 
lesion cannot be ruled out. Also, in squamous cells: low-grade 
intraepithelial lesion (LSIL), HPV-compatible cytopathic 
effect and cervical intraepithelial neoplasia I (CIN I); high-
grade intraepithelial lesion (HSIL), comprising cervical 
intraepithelial neoplasia II and III (CIN II and III); high-grade 
intraepithelial lesion, and could not exclude microinvasion and 
invasive squamous cell carcinoma. And in glandular cells: in 
situ adenocarcinoma (ISA) and invasive adenocarcinoma.15
Quantitative variables were described by mean and 
standard deviation or median and interquartile range, 
depending on the distribution of the data. This distribution 
was evaluated by the Kolmogorov-Smirnov test. Categorical 
variables were described by absolute and relative frequencies. 
The level of significance was 5% (p≤0.05).
This study was carried out according to the Resolution No. 
466 of 2012.16 It was also submitted to the ethical assessment 
of the Universidade do Vale do Rio dos Sinos (UNISINOS), then 
obtaining approval under the Legal Opinion No. 1.363.029.
RESULTS
Concerning the cytology, 45.7% of the reports had only 
squamous epithelium and 54.3% contained the description 
of squamous and glandular epithelium. The total of the 
exams studied, close to 3%, were within normal limits. 
Concerning benign or reparative alterations, the majority 
had no alterations, 16.4% had inflammation, and 14.9% had 
atrophy with inflammation. Considering the microbiology, 
44.5% described the presence of lactobacilli; 14% of cocci; 
and 12% reported Gardnerella vaginalis. As for endometrial 
cells, none of the reports recorded them. Bearing in mind 
the total sample, six women had their tests within normal 
limits (Table 1).
Tabele 1 - Characterization of the sample in regards to the 
description of the cytopathological reports from the FHS 
service located in the Metropolitan Area of Porto Alegre city. 
January 2014 to December 2015.
Cytopathological profile n (%)
Epithelium 197 (98)
Squamous 90 (45.7)
Squamous and glandular 107 (54.3)
Benign or reparative alterations 201 (100)
No alterations 137 (68.2)
Inflammation 33 (16.4)
Atrophy with inflammation 30 (14.9)
Inflammation and repair 1 (0.5)
Microbiology 200 (99.5)
Flora absent 17 (8.5)
Lactobacillus 89 (44.5)
Gardnerella vaginalis 24 (12.0)
Coccus 28 (14.0)
Lactobacillus and coccus 16 (8.0)
Lactobacillus, coccus and Candida sp 1 (0.5)
Lactobacillus and Candida sp 2 (1.0)
Candida sp and Gardnerella sp 1 (0.5)
No alterations 22 (11.0)
Presence of endometrial cells 201 (100)
No 201 (100)
Yes 0 (0.0)
*Considering the total sample, 2.98% (6) of the women presented a result 
described as within the limit of normality.
Source: Primed by the authors. Research data (2016).
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Concerning the exams’ results, most of the medical records 
contained reports that showed atypical cells of indeterminate 
significance, in which the squamous epithelium presented 
the following percentage: 100% of the exams had a diagnosis 
“possibly non-neoplastic” (ASC-US). Regarding the glandular 
cells, 11.52% of the reports were registered as “undiagnosed”; 
88.48% as “possibly non-neoplastic” (AGUS) (Figure 1). 
Figure 1 - Sample distribution with regards to the cases of 
atypical cells (n = 191) in cytopathological reports from the 
FHS service located in the Metropolitan Area of Porto Alegre 
city. January 2014 to December 2015.
Source: Primed by the authors. Research data (2016).
Considering the total sample, four women presented 
neoplasia, representing a prevalence of 2%, occurring in 
50% of the LSIL-HPV (CIN I) records; 25% HSIL (CIN II 
and III); and 25% ISA.
Regarding the profile of the users, they had an average 
age of 40.2 years old, 74.5% declared themselves married 
and were literate. Of the total number of records analyzed, 
134 had records regarding the occupation, 48.5% reported 
being home, 10.5% had some paid profession, and the rest 
of the medical records presented conditions either as student 
or unemployed. The most used contraceptive method was 
oral contraceptive, however, 36% of the users did not use any 
contraceptive method and the mairia said not to be smoker.
According to the records, 5.7% of the women were pregnant 
at the time of collection for cytopathological examination. 
Furthermore, 49.1% of the women had a history of cancer in 
the family, in which 18 of them had first-degree kinship with 
the affected person, one of whom underwent radiotherapy 
and chemotherapy to treat cancer (Table 2).
Table 2 - Characterization of the sample regarding the 
sociodemographic and reproductive profile of women from 
the FHS service located in the Metropolitan Area of Porto 
Alegre city. January 2014 to December 2015.
Characterization Sample n(%)
Descriptive 
Statistics
Age (years old) – average ± SD 190 (94.5) 40.2 ± 14.2
Marital status – 47 (23.4)
Married 35 (74.5)
Single 6 (12.8)
Widow 3 (6.4)
Divorced 3 (6.4)
Schooling 87 (43.3)
Literate 86 (98.9)
Illiterate 1 (1.1)
Most frequent occupation 134 (66.7)
Housewife 65 (48.5)
General assistant 10 (7.5)
Student 6 (4.5)
Unemployed 5 (3.7)
Cooking 4 (3.0)
Smoking 81 (40.3)
Yes 18 (22.2)
No 63 (77.8)
Age of menarche (years old) - 
average ± SD 11 (5.5) 12.3 ± 1.0
Contraceptive method 100 (49.8)
none 36 (36.0)
Contraceptive pill 33 (33.0)
Condom 9 (9.0)
Injectable 15 (15.0)
IUD 3 (3.0)
Contraceptive pill and condom 4 (4.0)
Current pregnancy 122 (60.7)
Yes 7 (5.7)
No 115 (94.3)
Number of pregnancies - md 
(P25 - P75) 93 (46.3) 2 (1 – 4)
Number of births (P25 - P75) 84 (41.8) 1 (0 – 3)
Number of cesarean sections - 
md (P25 - P75) 84 (41.8) 0 (0 – 1)
Abortion 84 (41.8) 19 (22.6)
Nulliparous 92 (45.8) 14 (15.2)
Age of 1st gestation - average 
± SD 10 (5.0) 18.7 ± 5.0
Cancer history* 53 (26.4) 26 (49.1)
*18 people showed first-degree kinship (69.2%) and 1 person underwent 
radiotherapy and chemotherapy (3.8%).
Source: Primed by the authors. Research data (2016).
Most of the women had the screening test, and 96.9% 
had already taken the test in their lifetime. According to the 
medical records, 86.7% of the women did not experience 
bleeding after sexual intercourse. Moreover, 70.8% did not 
have STIs. Nonetheless, 4.6% of the women had a diagnosis 
of syphilis, 8.5% of HPV, 15.4% of bacterial vaginosis and 
0.8% of genital herpes. Regarding the inspection of the cervix 
in the collection of the exam, most 91.4% had apparently 
normal cervix (Table 3).
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Table 3 - Characterization of the sample concerning the 
clinical and gynecological data of women from the FHS 
service located in the Metropolitan Area of Porto Alegre city. 
January 2014 to December 2015.
Sample characterization 
Total 
sample 
n(%)
Descriptive 
Statistics
Reason for examination 140 (69.7)
Tracking 139 (99.3)
Follow-up/treatment 1 (0.7)
Have you ever done it before? 129 (64.2)
Yes 125 (96.9)
No 4 (3.1)
Time of last exam (years) - md 
(P25 - P75) 122 (60.7) 2 (1 – 3)
Regularity 124 (61.7)
Once a year 48 (38.7)
Every 6 months 4 (3.2)
Every 4 months 1 (0.8)
More than 1 time per year 71 (57.3)
Bleeding during the intercourse 128 (63.7) 
Yes 17 (13.3)
No 111 (86.7)
STIs 130 (64.7)
No 92 (70.8)
Syphilis 6 (4.6)
HPV 11 (8.5)
Bacterial vaginosis 20 (15.4)
Genital herpes 1 (0.8)
Cervix 139 (69.2)
Absent 1 (0.7)
Normal 127 (91.4)
Altered 2 (1.4)
Not seen 9 (6.5)
Source: Primed by the authors. Research data (2016).
DISCUSSION
CC is the second most common cancer and the second 
leading cause of cancer death among women in many 
developed and developing countries. Yet, in the most deprived 
regions, it is the one with the highest incidence; responsible 
for the majority of cancer deaths among women.17 Still, 
periodic cytopathological examination is the most adopted 
strategy for the CC screening. Achieving high coverage of 
the target population is the most important component in 
the primary care area in order to obtain a relevant reduction 
in the incidence and mortality of this type of cancer.9
The WHO recommends that screening for CC prevention 
should be done preferably in women within the age group from 
25 to 65 years old. However, the study registered an average of 
40 years for women who sought the test, thus suggesting the 
need for active search of users in the screening age, aiming at 
greater coverage and follow-up of this population.9 As for the 
insertion of women in the market 50% of the women with a 
CC register reported being from the home or unemployed, 
diverging from the results found by Casarin and Piccoli18 in 
a similar survey, where 72% of respondents reported having 
paid work. The authors believe that, as women expand their 
presence in the professional field, there are changes in their 
roles, lifestyle and family patterns, which may be related to 
nullity or reduction in the number of children.18
In this perspective, the Ministry of Health states that 
smoking increases the risk of developing CC and emphasizes 
that controlling this habit can reduce the risks related to 
this neoplasm, which is one of the priorities of the National 
Health Promotion Policy.9 Smoking and drug use could not 
be evaluated for association with CC, since this data was not 
included in the records analyzed in this study.
Another factor that may be related to illness is the 
use of hormonal contraceptives. Corroborating this 
statement, Angels, and colleagues,13 affirm that the use of 
oral contraceptives, among other variables, was associated 
with cervical lesions. Still, with regard to the use of oral 
contraceptives, Casarin and Piccoli,18 emphasize that the 
association, if any, between the use of oral contraceptives and 
the risk of CC, is made with difficulties. Oral contraceptives 
are used by sexually active women and are less likely to use 
barrier methods and are therefore more at risk of contracting 
STIs such as HPV. On the other hand, these women attend 
the gynecologist more, and are more likely to be screened 
for CC. Nonetheless, the present study made it possible to 
observe that among the women with a positive result for CC, 
only two records included registration of contraceptive use, 
only one used oral contraceptive and the other did not use 
any contraceptive method.
For Casarin and Piccoli, the multiplicity of partners 
and the infection by STIs are related to the development 
of CC. STI presence, in addition to increasing the risk of 
contracting and transmitting HIV, can also cause wounds and 
inflammation in the mucous membranes and the skin of the 
genitals. In addition, if they are not treated properly they can 
become precancerous lesions, benign or reparative changes 
that can lead to CC.18 Yet, in the sample surveyed, there was 
a predominance of users who declared themselves married, 
suggesting a fixed partner. Additionally, there was also a 
prevalence of records with an absence of STIs on inspection 
of the uterine cervix. In the sample with a positive result for 
CC, three records had a registry informing about the presence 
of STIs, of this total, only one containing the registry of HPV.
HPV is recognized as an STI precursor to CC. According 
to Rama et al.,19 the highest prevalence of HPV is found in 
women under the age of 25 years old, with a progressive 
linear decline after this age, due to changes in sexual habits, 
making them less exposed. Such information corroborates 
with the data found in this study, where cervical lesions from 
HPV also appear to be more prevalent among young women 
under the age of 25 years old.
Vaginal dyspnea and vaginal bleeding after sexual 
rebound are a sign and clinical symptom that may be related 
to dysplasia or cervical cancer. Bleeding can be caused by 
vaginal infections, cervical or cervical infections, or even by 
STIs.18 Nevertheless, the present study showed that 86.7% of 
women did not experience bleeding after intercourse.
For the cytological result, benign alterations are 
considered: presence of inflammation, repair, atrophy, 
metaplasia or radiation.9 Herein, benign cervical lesions were 
DOI: 10.9789/2175-5361.2019.v11i1.192-198
Profile of cytopathologic exams collected in a family health strategy
ISSN 2175-5361
DiasCF; MichelettiVCD; FronzaE; et al.
197J. res.: fundam. care. online 2019 jan/mar 11(1): 192-198
found, so that the presence of inflammation and atrophy 
with inflammation are the most frequent. Atrophy with 
inflammation is a normal finding in the climacteric period 
and only requires gynecological attention if it is associated 
with symptoms such as vaginal dryness and dyspareunia.9 A 
study performed by Moraes and Jerônimo,20 in Bandeirantes 
city, Paraná State, with 52.37% of benign cellular alterations, 
mainly inflammation, metaplasia, and atrophy, differ from 
the findings of the current study.
Microbiological alterations were found in most of the 
tests analyzed. Nonetheless, the presence of microorganisms 
that are part of the vaginal flora is already expected, so this 
does not characterize the existence of infections that require 
treatment. Among these microorganisms found, we can 
mention Lactobacillus sp, cocci, and other bacilli.20
The incidence of CC has been higher in the age group 
from 40 to 60 years old. The lower frequency before the age 
of 30 may be related to the time course of HPV infections.6 
In the present study, the prevalence of CC cases was found to 
be concentrated in the age range of 37 to 57 years old, with a 
total of three cases. Diverging from the findings found in the 
research by Ströher and his colleagues,12 where the majority 
of women were younger than 25 years. However, this picture 
has been gradually changing, and the appearance of precursor 
lesions is occurring earlier, also due to the early initiation of 
sexual activity and its association with other risk factors.12
Regarding the diagnosis of ASC US or atypicals of 
undetermined significance in glandular cells, possibly not 
neoplastic, it is recommended not to exceed 5% of all diagnoses 
in the same laboratory.21 For Ströher et al.,12 ASC-US is the 
most found in examinations processed in the cytology 
laboratories. He believes that the high number of ASC-US 
results is linked to diagnostic difficulties due to problems in 
the collection and analysis of cytological slides and limitations 
of public health services.12 The registries analyzed showed a 
predominance of ASC-US, followed by CIN I; CIN II and III.
It is believed that the quality of the collection and 
packaging of the cytopathological examinations, as well as 
the adequate transport of the samples, is fundamental for the 
success of the CC screening. The satisfactory collection of the 
smear implies the presence of cells in a significant quantity, 
well distributed, fixed and stained, in such a way that their 
visualization allows the diagnostic conclusion.9
These findings point to the need of training and motivating 
health professionals in order to get them to perform the correct 
Pap smear, systematically and within organized programs for 
the detection and treatment of percussive lesions.17
CONCLUSIONS
In 2014 and 2015, 350 cytopathological exams were 
performed, of which 201 were included in the current 
study. Through this study was possible to know the profile 
of cytopathological examination collected in a FHS of the 
metropolitan region of Porto Alegre city.
Bearing in mind the total number of cytopathological 
exams analyzed, only the presence of squamous epithelium 
was recorded. Considering the cell changes, there was a 
predominance of ASC-US, which may be related to the quality 
of the screening process of the cytopathological examination 
and the laboratory analysis of the samples.
It is suggested that new discussions and studies be carried 
out with emphasis on the qualification of the collection 
process, the fixation of the material, the processing and the 
laboratory analysis of the cytopathological material, seeking 
to guarantee the diagnostic safety, treatment, and prevention 
of the progression of cytopathological lesions.
Active search strategies for screening for CC prevention 
can be implemented, such as registration protocols for women 
with cell changes and associated risk factors.
As a study limitation, it can be highlighted the relatively 
small sample and the lack of records related to the studied 
variables as risk factors, such as the previous history of STI, 
color, education, alcohol and drug consumption, BMI; which 
may have compromised some study results.
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